GET THE APP
Smegmatis Tuberculosis Drugs | Open Access Journals
..

Journal of Infectious Diseases and Medicine

ISSN: 2576-1420

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Smegmatis Tuberculosis Drugs

Mycobacterium smegmatis is an acid-fast bacterial species within the phylum Actinobacteria and the class Mycobacterium.  It is 3.0 to 5.0 µm long with a bacillus shape and can be recolored by Ziehl-Neelsen strategy and the auramine-rhodamine fluorescent strategy. It was to begin with detailed in November 1884 by Lustgarten, who found a bacillus with the recoloring appearance of tubercle bacilli in syphilitic chancres. Ensuing to this, Alvarez and Tavel found living beings comparative to that depicted by Lustgarten too in ordinary genital emissions (smegma). This life form was afterward named M. smegmatis. M. smegmatis is by and large considered a non-pathogenic microorganism; in any case, in a few exceptionally uncommon cases, it may cause disease.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Immunology & Microbiology

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 59

Journal of Infectious Diseases and Medicine received 59 citations as per Google Scholar report

Citation image
Journal of Infectious Diseases and Medicine peer review process verified at publons
Publon image

Indexed In

Related Links

PMC/PubMed Indexed Articles
Improving STI and HIV Passive Partner Notification using the Model for Improvement: A Quality Improvement Study in Lilongwe Malawi
Health System Factors Influencing Partner Notification for STIs and HIV in Lilongwe Malawi. A Pre-intervention Phase Assessment for a Quality Improvement Project

View More »

 

Open Access Journals

arrow_upward arrow_upward